Skip to main content

Table 2 Objective sleep quality at baseline, N = 15.

From: Medroxyprogesterone improves nocturnal breathing in postmenopausal women with chronic obstructive pulmonary disease

Sleep Recording Data at Baseline

 

TST

4 h 34 min ± 1 h 13 min

Sleep efficiency

66 ± 18 % of sleep period time

EEG arousals

2.6 ± 3.3 / h of sleep

Movement arousals

9.7 ± 7.1 / h of sleep

Latency to S2 sleep

41 ± 41 min

Stage S1 sleep

87 ± 60 min (34 ± 24 %)

Stage S2 sleep

81 ± 48 min (29 ± 15 %)

SWS

73 ± 39 min (26 ± 10 %)

REM sleep

34 ± 31 min (11 ± 10 %)

  1. Percentages indicate proportion of the total sleep time (TST) unless otherwise indicated. Data presented as mean ± SD. REM = rapid eye movements, SWS = slow wave sleep (sleep stages 3 and 4), TST = total sleep time.